Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2009 1
2012 1
2013 2
2016 2
2017 1
2018 1
2019 2
2020 1
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Fine-needle aspiration biopsy for suspected uveal metastases.
Bellerive C, Biscotti CV, Singh N, Singh AD. Bellerive C, et al. Can J Ophthalmol. 2019 Dec;54(6):694-698. doi: 10.1016/j.jcjo.2019.03.016. Epub 2019 May 31. Can J Ophthalmol. 2019. PMID: 31836102
The metastasis-positive cases included 9 adenocarcinoma, 3 uveal lymphoma, 3 small cell carcinomas, 3 non-small cell carcinomas, and 1 metastatic paraganglioma. Both of the atypical cases were suggestive for non-Hodgkin lymphoma. ...
The metastasis-positive cases included 9 adenocarcinoma, 3 uveal lymphoma, 3 small cell carcinomas, 3 non-small cell carcinomas, and 1 me …
The phenotype of SDHB germline mutation carriers: a nationwide study.
Niemeijer ND, Rijken JA, Eijkelenkamp K, van der Horst-Schrivers ANA, Kerstens MN, Tops CMJ, van Berkel A, Timmers HJLM, Kunst HPM, Leemans CR, Bisschop PH, Dreijerink KMA, van Dooren MF, Bayley JP, Pereira AM, Jansen JC, Hes FJ, Hensen EF, Corssmit EPM. Niemeijer ND, et al. Eur J Endocrinol. 2017 Aug;177(2):115-125. doi: 10.1530/EJE-17-0074. Epub 2017 May 10. Eur J Endocrinol. 2017. PMID: 28490599
Fifty-four mutation carriers (27.8%) had one or multiple head and neck paragangliomas, 4 (2.1%) had a pheochromocytoma and 26 (13.4%) had one or more sympathetic paragangliomas. Fifteen patients (7.7%) developed metastatic paraganglioma and 17 (8.8%) developed non-p …
Fifty-four mutation carriers (27.8%) had one or multiple head and neck paragangliomas, 4 (2.1%) had a pheochromocytoma and 26 (13.4%) had on …
Glutamine Synthetase Immunoreactivity in Peritumoral Hyperplasia in Liver: Case Report of a Metastatic Paraganglioma With Focal Nodular Hyperplasia-Like Changes and Review of an Additional 54 Liver Masses.
Bryant BH, Zenali MJ, Swanson PE, Upton MP, Yeh MM, Cuevas C, Park JO, Westerhoff M. Bryant BH, et al. Am J Clin Pathol. 2016 Aug;146(2):254-61. doi: 10.1093/ajcp/aqw056. Epub 2016 May 31. Am J Clin Pathol. 2016. PMID: 27247379 Review.
OBJECTIVES: Focal nodular hyperplasia (FNH) and peritumoral hyperplasia in the liver exhibit increased immunoreactivity for glutamine synthetase (GS). We observed FNH-like changes with map-like GS staining surrounding a metastatic paraganglioma and sought to …
OBJECTIVES: Focal nodular hyperplasia (FNH) and peritumoral hyperplasia in the liver exhibit increased immunoreactivity for glutamine synthe …
Sunitinib for the treatment of metastatic paraganglioma and vasoactive intestinal polypeptide-producing tumor (VIPoma).
Bourcier ME, Vinik AI. Bourcier ME, et al. Pancreas. 2013 Mar;42(2):348-52. doi: 10.1097/MPA.0b013e31825c53fa. Pancreas. 2013. PMID: 23407483
METHODS: The patients were a 12-year-old boy with metastatic vasoactive intestinal polypeptide-producing tumor (VIPoma) and a 70-year-old woman with metastatic paraganglioma/NET. Both were treated in an outpatient clinical setting. ...RESULTS: The patient with the p …
METHODS: The patients were a 12-year-old boy with metastatic vasoactive intestinal polypeptide-producing tumor (VIPoma) and a 70-year-old wo …
Urinary bladder malignant paraganglioma with vertebral metastasis: a case report with literature review.
Feng N, Li X, Gao HD, Liu ZL, Shi LJ, Liu WZ. Feng N, et al. Chin J Cancer. 2013 Nov;32(11):624-8. doi: 10.5732/cjc.012.10317. Epub 2013 May 14. Chin J Cancer. 2013. PMID: 23668927 Free PMC article. Review.
Paraganglioma is a rare neuroendocrine neoplasm observed in patients of all ages, with an estimated incidence of 3/1,000,000 population. ...Some tumors show gross local invasion and recurrence, which may indeed kill the patient, but this does not necessarily associate with …
Paraganglioma is a rare neuroendocrine neoplasm observed in patients of all ages, with an estimated incidence of 3/1,000,000 populati …
Case Report: Primary Hypothyroidism Associated With Lutetium 177-DOTATATE Therapy for Metastatic Paraganglioma.
Gubbi S, Al-Jundi M, Del Rivero J, Jha A, Knue M, Zou J, Turkbey B, Carrasquillo JA, Lin E, Pacak K, Klubo-Gwiezdzinska J, Lin FI. Gubbi S, et al. Front Endocrinol (Lausanne). 2021 Jan 21;11:587065. doi: 10.3389/fendo.2020.587065. eCollection 2020. Front Endocrinol (Lausanne). 2021. PMID: 33551992 Free PMC article. Clinical Trial.
Data on (177)Lu-DOTATATE-induced thyroid dysfunction is limited. CASE DESCRIPTION: A 29-year-old male with SDHB positive metastatic paraganglioma enrolled under the (177)Lu-DOTATATE trial (NCT03206060) underwent thyroid function test (TFT) evaluation comprised of th …
Data on (177)Lu-DOTATATE-induced thyroid dysfunction is limited. CASE DESCRIPTION: A 29-year-old male with SDHB positive metastatic …
Paraganglioma of the spine: A twenty-years clinical experience of a high volume tumor center.
Pipola V, Boriani S, Bandiera S, Righi A, Barbanti Bròdano G, Terzi S, Ghermandi R, Tedesco G, Evangelisti G, Girolami M, Gasbarrini A. Pipola V, et al. J Clin Neurosci. 2019 Aug;66:7-11. doi: 10.1016/j.jocn.2019.05.037. Epub 2019 May 29. J Clin Neurosci. 2019. PMID: 31153748
The aim of this paper is to evaluate clinical outcomes of surgical treatment of a rare disease that can involve the spine and that should be considered in the differential diagnosis of spinal injuries. This is a retrospective observational study of the spinal paraganglioma …
The aim of this paper is to evaluate clinical outcomes of surgical treatment of a rare disease that can involve the spine and that should be …
Hereditary pheochromocytoma/paraganglioma syndrome with a novel mutation in the succinate dehydrogenase subunit B gene in a Japanese family: two case reports.
Hirose R, Tsurutani Y, Sugisawa C, Inoue K, Suematsu S, Nagata M, Hasegawa N, Kakuta Y, Yonamine M, Takekoshi K, Kimura N, Saito J, Nishikawa T. Hirose R, et al. J Med Case Rep. 2021 May 22;15(1):282. doi: 10.1186/s13256-021-02852-z. J Med Case Rep. 2021. PMID: 34020699 Free PMC article.
CASE PRESENTATION: A 19-year-old Japanese woman, whose father died of metastatic paraganglioma, was diagnosed with abdominal paraganglioma, and underwent total resection. ...Afterwards, the same succinate dehydrogenase subunit B mutation was detected in her father's …
CASE PRESENTATION: A 19-year-old Japanese woman, whose father died of metastatic paraganglioma, was diagnosed with abdominal p …
[131I]-TYR3-octreotide: clinical dosimetry and use for internal radiotherapy of metastatic paraganglioma and carcinoid tumors.
Baulieu J, Resche I, Bardies M, Chauvet AF, Lecloirec J, Malhaire J, Thomas E, Faurous P, Sassolas G, Pourcelot L, Chatal J, Guilloteau D, Besnard JC. Baulieu J, et al. Nucl Med Biol. 2000 Nov;27(8):809-813. doi: 10.1016/s0969-8051(00)00150-5. Nucl Med Biol. 2000. PMID: 11150715
Dosimetry and therapeutic application of [(131)I]-Tyr3-octreotide were evaluated in three patients with metastatic paraganglioma and carcinoid tumor. The in vitro stability of [(131)I]-Tyr3-octreotide was verified. ...The calculated tumor radiation doses were betwee …
Dosimetry and therapeutic application of [(131)I]-Tyr3-octreotide were evaluated in three patients with metastatic paraganglioma …
Arsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study.
Modak S, Zanzonico P, Carrasquillo JA, Kushner BH, Kramer K, Cheung NK, Larson SM, Pandit-Taskar N. Modak S, et al. J Nucl Med. 2016 Feb;57(2):231-7. doi: 10.2967/jnumed.115.161752. Epub 2016 Jan 7. J Nucl Med. 2016. PMID: 26742708 Free PMC article. Clinical Trial.
METHODS: Patients with recurrent or refractory stage 4 neuroblastoma or metastatic paraganglioma/pheochromocytoma (MP) were treated using an institutional review board-approved protocol (Clinicaltrials.gov identifier NCT00107289). ...By International Neuroblastoma R …
METHODS: Patients with recurrent or refractory stage 4 neuroblastoma or metastatic paraganglioma/pheochromocytoma (MP) were tr …
13 results